Severe Hepatitis C Reactivation As an Early Complication of Hematopoietic Cell Transplantation

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2016 Jul 19

PMID 27427916

Citations 8

Authors

N T Oliver

Y L Nieto

B Blechacz

P Anderlini

E Ariza-Heredia

H A Torres

Affiliations

Soon will be listed here.

Citing Articles

Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation.

Kamel N, Abdalla M, Al Ali A, Alshahrani M, Aboshanab K, El Borhamy M Infect Drug Resist. 2024; 17:2249-2260.

PMID: 38854781 PMC: 11162205. DOI: 10.2147/IDR.S463868.

Prevalence and clinical consequences of Hepatitis C virus infection in patients undergoing hematopoietic stem cell transplantation.

Diaz A, Witkin S, Almeida Neto C, Mendrone Junior A, Rocha V, Costa S Rev Inst Med Trop Sao Paulo. 2024; 66:e11.

PMID: 38324877 PMC: 10846481. DOI: 10.1590/S1678-9946202466011.

Chronic Hepatitis C: Acute Exacerbation and Alanine Aminotransferase Flare.

Kanda T, Matsumoto N, Ishii T, Arima S, Shibuya S, Honda M Viruses. 2023; 15(1).

PMID: 36680223 PMC: 9861769. DOI: 10.3390/v15010183.

Acute Hepatitis C After Penile Stem Cell Injection.

Zaveri S, Tagliaferri A, Shah B, Melki G, Michael P Cureus. 2022; 14(11):e31858.

PMID: 36579246 PMC: 9789745. DOI: 10.7759/cureus.31858.

Effects of dual plasma molecular adsorption system on liver function, electrolytes, inflammation, and immunity in patients with chronic severe hepatitis.

Chen G, Wu M, Wu B, Liu F, Liu J, Liu L J Clin Lab Anal. 2019; 33(7):e22926.

PMID: 31206768 PMC: 6757123. DOI: 10.1002/jcla.22926.

References

Mahale P, Kontoyiannis D, Chemaly R, Jiang Y, Hwang J, Davila M . Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012; 57(6):1177-85. DOI: 10.1016/j.jhep.2012.07.031. View

Torres H, Chong P, de Lima M, Friedman M, Giralt S, Hammond S . Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations. Biol Blood Marrow Transplant. 2015; 21(11):1870-82. DOI: 10.1016/j.bbmt.2015.07.033. View

Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L . Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996; 87(10):4296-301. View

Smith B, Morgan R, Beckett G, Falck-Ytter Y, Holtzman D, Teo C . Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012; 61(RR-4):1-32. View

Evans A, Loeb K, Shulman H, Hassan S, Qiu W, Hockenbery D . Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases. Am J Surg Pathol. 2014; 39(2):212-20. DOI: 10.1097/PAS.0000000000000345. View

Ramos C, Saliba R, de Padua L, Khorshid O, Shpall E, Giralt S . Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica. 2009; 94(2):249-57. PMC: 2635398. DOI: 10.3324/haematol.13756. View

Torres H, Mahale P, Blechacz B, Miller E, Kaseb A, Herlong H . Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population. J Natl Compr Canc Netw. 2015; 13(1):41-50. DOI: 10.6004/jnccn.2015.0007. View

Kohrt H, Ouyang D, Keeffe E . Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment Pharmacol Ther. 2006; 24(7):1003-16. DOI: 10.1111/j.1365-2036.2006.03081.x. View

Peffault de Latour R, Levy V, Asselah T, Marcellin P, Scieux C, Ades L . Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood. 2003; 103(5):1618-24. DOI: 10.1182/blood-2003-06-2145. View

10.

Kyvernitakis A, Mahale P, Popat U, Jiang Y, Hosry J, Champlin R . Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents. Biol Blood Marrow Transplant. 2015; 22(4):717-722. PMC: 4828726. DOI: 10.1016/j.bbmt.2015.12.010. View

11.

Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo M . Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Haematologica. 2004; 89(1):70-6. View

12.

Anoop P, Wotherspoon A, Matutes E . Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia. Br J Haematol. 2009; 148(3):484-6. DOI: 10.1111/j.1365-2141.2009.07972.x. View

13.

Mahale P, Thomas S, Kyvernitakis A, Torres H . Management of Multiple Myeloma Complicated by Hepatitis C Virus Reactivation: The Role of New Antiviral Therapy. Open Forum Infect Dis. 2016; 3(1):ofv211. PMC: 4751339. DOI: 10.1093/ofid/ofv211. View